Yoon Hang Kim, MD, MPH

Board-Certified in Preventive Medicine | Integrative & Functional Medicine Physician

Aspirin is one of the oldest and most studied medications in the world, and it remains a cornerstone of cardiovascular care for many people who have already had a heart attack, stroke, or coronary stent placed. But aspirin is not a harmless daily supplement. It is a drug that changes how blood clots, and that same mechanism that protects against a second heart attack is the mechanism that can cause serious bleeding. Understanding that trade-off is essential for anyone taking aspirin regularly, whether it was recommended for secondary prevention after a cardiovascular event or is being considered for primary prevention in someone who has never had one.

How Aspirin Increases Bleeding Risk

Aspirin works by irreversibly inhibiting the enzyme cyclooxygenase-1 (COX-1) inside platelets. This blocks platelets from producing thromboxane A2, a signaling molecule platelets use to activate one another and clump together at a site of vessel injury. Because platelets cannot make new COX-1 once aspirin has bound it, the effect lasts for the entire 7- to 10-day lifespan of the affected platelet, even though aspirin itself clears from the bloodstream within hours. This is why a single missed dose does not restore normal clotting, and why aspirin's antiplatelet effect is far more durable than its short half-life would suggest.

The same COX-1 pathway also protects the stomach lining by supporting mucus and bicarbonate production and gastric blood flow. Suppressing it leaves the gastric and duodenal mucosa more vulnerable to acid injury, which is why gastrointestinal bleeding, ranging from occult blood loss to major upper GI hemorrhage, is the most common serious bleeding complication of aspirin therapy. Intracranial (hemorrhagic stroke) and other extracranial bleeding are less common but more dangerous when they occur.

Why Bleeding Risk Has Become Central to the Aspirin Conversation

The clinical calculus around aspirin has shifted meaningfully over the past several years. For secondary prevention — people who have already had a heart attack, ischemic stroke, or coronary intervention — low-dose aspirin remains recommended because the reduction in recurrent vascular events generally outweighs the bleeding risk. For primary prevention, the picture is different. 

Large trials informing the 2022 USPSTF recommendations, including ARRIVE, ASCEND, and ASPREE, found that the modest cardiovascular benefit of starting aspirin in people without established cardiovascular disease was largely offset by increased bleeding.

As a result, current guidance recommends against routine use of primary-prevention aspirin in adults over 70 or in anyone with an elevated bleeding risk, and frames aspirin as something to consider only in select adults age 40 to 70 with elevated cardiovascular risk and no increased bleeding risk.

In the setting of acute coronary syndrome and dual antiplatelet therapy, more recent 2025 ACC/AHA guidance builds in bleeding-mitigation strategies directly, including proton pump inhibitor use for those at gastrointestinal risk, transition to single-agent therapy (often dropping aspirin rather than the P2Y12 inhibitor) after an initial period in selected patients, and early discontinuation of aspirin in patients who also require long-term anticoagulation.

Who Is at Highest Risk of Aspirin-Related Bleeding

Bleeding risk with aspirin is not uniform. It concentrates heavily in people with one or more of the following factors, which is why an individualized risk assessment matters more than a blanket rule:

Strategies to Reduce Bleeding Risk While on Aspirin

1. Use the Lowest Effective Dose

Most cardiovascular protection from aspirin is achieved at low doses (75 to 100 mg daily), and higher doses add bleeding risk without added benefit for most indications. For clients who have been on higher, legacy doses, a dose review with the prescribing physician is often a straightforward first step toward lowering bleeding risk without sacrificing protection.

2. Consider Gastroprotection With a PPI

For clients with elevated gastrointestinal risk factors, such as prior ulcer or GI bleeding, advanced age, or concurrent NSAID, corticosteroid, or anticoagulant use, co-prescribing a proton pump inhibitor substantially lowers the risk of recurrent ulcer bleeding. In a randomized trial of high-risk aspirin users with a prior bleeding ulcer, recurrent upper GI bleeding occurred in less than 1% of those on a PPI over 12 months, meaningfully lower than in those managed with an H2-blocker alone.

PPIs are not appropriate as an indefinite default for every aspirin user, since long-term PPI use carries its own considerations (nutrient absorption, kidney and bone health, and possibly gastric cancer risk in specific contexts). The goal is to target gastroprotection to those who actually need it, and to periodically reassess whether ongoing PPI therapy still makes sense.

3. Test and Treat for H. pylori Before or Early in Aspirin Therapy

Helicobacter pylori infection and aspirin use act as independent, additive risk factors for peptic ulcer bleeding. Current guidance recommends testing for H. pylori in aspirin users who are otherwise at higher ulcer risk, and eradicating the infection when present, as a meaningful secondary-prevention step, in addition to, rather than instead of, standard gastroprotective strategies.

4. Minimize Concurrent NSAID Use

Combining aspirin with ibuprofen, naproxen, or other NSAIDs compounds gastrointestinal risk substantially, and ibuprofen taken around the same time as aspirin can also blunt aspirin's platelet-inhibiting effect. Clients on daily aspirin who need pain relief are generally better served by acetaminophen when appropriate, or by a deliberate conversation with their physician about timing and alternatives if an NSAID is truly needed.

5. Reconcile the Full Medication and Supplement List

Bleeding risk climbs when aspirin is combined with other antiplatelet agents, anticoagulants, SSRIs or SNRIs (which impair platelet serotonin uptake and function), or systemic corticosteroids. From an integrative standpoint, it is also worth flagging that several commonly used nutraceuticals, including high-dose fish oil, vitamin E, ginkgo biloba, and high-dose curcumin, have their own mild antiplatelet or anticoagulant properties. These are not automatically contraindicated, but they deserve the same deliberate review as prescription medications, particularly before any planned procedure or if a client is already at elevated bleeding risk.

6. Address Modifiable Lifestyle Contributors

Uncontrolled hypertension raises the risk of hemorrhagic stroke independent of aspirin, so blood pressure control is itself a bleeding-risk-reduction strategy. Heavy or regular alcohol use compounds gastric mucosal injury and impairs clotting factor synthesis when liver function is affected, so reducing alcohol intake is a genuinely protective step for anyone on long-term aspirin.

7. Periprocedural Planning

Whether aspirin should be paused before a surgery, dental procedure, or endoscopy depends entirely on the individual's cardiovascular risk versus procedural bleeding risk, and this decision should always be made together with the prescribing physician and the proceduralist rather than by unilaterally stopping the medication. Abruptly discontinuing aspirin in someone with a coronary stent, for example, carries its own serious risk of clot formation.

8. Know the Warning Signs and Act Early

Clients on aspirin should be aware of the signs that warrant prompt medical attention: black or tarry stools, vomiting blood or material resembling coffee grounds, unusual or spreading bruising, nosebleeds that are difficult to stop, blood in urine, or any sudden, severe headache. These symptoms should never be attributed to "just aspirin" without evaluation.

A Functional Medicine Perspective: Strengthening the Gut, Not Just Suppressing Acid

Conventional bleeding-risk reduction leans heavily on acid suppression, and for good reason, but it addresses only one side of the equation. A functional and integrative approach asks a complementary question: rather than only turning down stomach acid, how do we strengthen the mucosal barrier itself and address the upstream drivers of vulnerability, such as Helicobacter pylori infection, an imbalanced gut microbiome, chronic inflammation, and impaired tissue repair?

This perspective also reckons with a real limitation of proton pump inhibitors. While PPIs reliably protect the stomach and duodenum, aspirin and NSAIDs can also injure the lower small intestine through a separate mechanism, and acid suppression does not protect there. In fact, evidence suggests PPIs may worsen this small-bowel injury by altering the gut microbiome. That nuance is one reason a barrier-support and root-cause strategy has appeal as a complement to, never a replacement for, appropriately targeted medical gastroprotection.

Evidence-Informed Mucosal-Support Nutraceuticals

A small number of nutraceuticals have direct human or mechanistic evidence for protecting the gastrointestinal lining against aspirin and NSAID injury. These are supportive adjuncts with promising but still limited evidence, and they should be used in coordination with a physician rather than as a substitute for the core strategies above:

Additional soothing, mucilaginous agents such as mastic gum, aloe vera, marshmallow root, and slippery elm are commonly used for gastric comfort and have a long traditional history, though rigorous human data specific to aspirin-induced injury are limited. They may reasonably be considered for symptomatic support in the right client, with the understanding that the evidence base is softer than for zinc-carnosine and DGL.

The Other Side of the Coin: Supplements That Add to Bleeding Risk

An integrative review of bleeding risk is incomplete without honestly naming the supplements that push in the opposite direction. Several widely used nutraceuticals have their own antiplatelet or anticoagulant activity and can compound aspirin's effect, especially at higher doses or in combination:

• High-dose fish oil (EPA/DHA) — mild antiplatelet effect; most relevant at multi-gram doses and around procedures.
• High-dose vitamin E — antiplatelet activity at high doses, which is why the combination with zinc-carnosine should be dosed thoughtfully rather than maximized.
• Ginkgo biloba — inhibits platelet-activating factor; case reports link it to bleeding when combined with antiplatelet agents.
• Garlic (concentrated extracts), ginger, and high-dose curcumin — each has modest antiplatelet properties worth accounting for.
• The cumulative stack — the concern is additive, so the full combination matters more than any single item.

None of these are automatically off-limits, but they deserve the same deliberate reconciliation as prescription medications, particularly before any planned surgery, dental work, or endoscopy, and especially in clients already carrying elevated bleeding risk.

Diet, Lifestyle, and Root-Cause Foundations

Finally, the terrain matters. An anti-inflammatory, whole-food dietary pattern supports mucosal integrity and overall vascular health; adequate protein supplies the raw material for the rapid epithelial turnover the gut lining depends on; and addressing H. pylori, moderating alcohol, not smoking, controlling blood pressure, and managing chronic stress all reduce the background vulnerability on which aspirin acts. In functional medicine terms, the goal is not simply to blunt a side effect but to build a more resilient host, so that any necessary aspirin therapy carries as low a risk as reasonably achievable.

The Bottom Line: An Individualized Decision

Aspirin therapy is never a one-size-fits-all decision, and neither is bleeding-risk reduction. The right combination of dose, gastroprotection, H. pylori management, medication reconciliation, and lifestyle adjustment depends on why aspirin was started in the first place, what else the client is taking, and what their individual bleeding risk profile looks like. For clients navigating these decisions, working with a physician who has the time to review the full picture, rather than a rushed, formulaic renewal, allows the risks and benefits to be weighed thoughtfully and revisited as circumstances change.

If you take aspirin and have questions about whether your current regimen still makes sense for you, www.directintegrativecare.com offers the individualized time and continuity to work through that assessment together.